Almirall, Uxbridge, won a GBP 12.4 million (excluding VAT) multiple awardees contract award from the Common Services Agency (the Authority) for the supply of a range of analgesic, anaesthetic, musculoskeletal and joint disease medicines (All other Analgesic, Anaesthetic Musculoskeletal and Joint Disease Medicines) (Contract Award Notice No.: 2016/S 005-005020; Lot No.: 7).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.315 EUR | -1.01% |
|
-0.90% | +10.56% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.56% | 2.11B | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- ALM Stock
- News Almirall, S.A.
- Almirall Wins GBP 12.4 Million Multiple Awardees Contract for Supplying Analgesic, Anaesthetic, Musculoskeletal and Joint Disease Medicines